Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ISHITA DRUGS vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ISHITA DRUGS   ACTAVIS
EQUITY SHARE DATA
    ISHITA DRUGS
Mar-23
ACTAVIS
Dec-18
ISHITA DRUGS/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs8016,173-   
Low Rs4010,849-   
Sales per share (Unadj.) Rs40.43,967.2-  
Earnings per share (Unadj.) Rs1.9-1,277.8-  
Cash flow per share (Unadj.) Rs2.4418.1-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs30.716,362.7-  
Shares outstanding (eoy) m2.99332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.53.4 43.3%   
Avg P/E ratio x30.8-10.6 -291.5%  
P/CF ratio (eoy) x25.232.3 77.9%  
Price / Book Value ratio x1.90.8 235.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m1784,493,661 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m80-   
Avg. sales/employee Rs Th078,075.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,148.2-  
INCOME DATA
Net Sales Rs m1211,319,477 0.0%  
Other income Rs m225,233 0.0%   
Total revenues Rs m1231,344,710 0.0%   
Gross profit Rs m834,577 0.0%  
Depreciation Rs m1564,048 0.0%   
Interest Rs m176,141 0.0%   
Profit before tax Rs m8-580,380 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0148,020 0.0%   
Tax Rs m2-7,355 -0.0%   
Profit after tax Rs m6-425,004 -0.0%  
Gross profit margin %6.32.6 240.8%  
Effective tax rate %25.91.3 2,046.6%   
Net profit margin %4.8-32.2 -14.8%  
BALANCE SHEET DATA
Current assets Rs m102541,181 0.0%   
Current liabilities Rs m20478,746 0.0%   
Net working cap to sales %67.64.7 1,427.6%  
Current ratio x5.01.1 445.1%  
Inventory Days Days10520 534.6%  
Debtors Days Days54,431,59966 82,087,813.3%  
Net fixed assets Rs m12149,357 0.0%   
Share capital Rs m300-   
"Free" reserves Rs m620-   
Net worth Rs m925,442,228 0.0%   
Long term debt Rs m01,916,406 0.0%   
Total assets Rs m1148,507,441 0.0%  
Interest coverage x15.4-6.6 -232.9%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.10.2 682.3%   
Return on assets %5.5-4.1 -134.9%  
Return on equity %6.3-7.8 -80.6%  
Return on capital %9.1-4.8 -187.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m170-   
CASH FLOW
From Operations Rs m-29471,400 -0.0%  
From Investments Rs m6258,973 0.0%  
From Financial Activity Rs m11-809,063 -0.0%  
Net Cashflow Rs m-13-78,298 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.58 Rs / USD

Compare ISHITA DRUGS With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ISHITA DRUGS With: INDOCO REMEDIES  CIPLA  ALBERT DAVID  EVEREST ORGANICS  LINK PHARMA  



Today's Market

Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.